About this trial
Focus groups to identify treatment needs and barriers to participation in the planned multinutrient study among racially and ethnically diverse (Black and Hispanic) communities.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult parents/caregivers self-identified as Black or Hispanic/Latino
With a family member 6-18 years old with suspected ADHD and/or emotional dysregulation, or provide care for, or teach someone who meets these criteria
Who have sought or are interested in treatment
Willing to discuss child's mental health care needs and provide feedback regarding feasibility study
Disqualifiers
Unwilling to be recorded
Trial population
Community samples of Portland, Oregon individuals who self-identify as Hispanic/Latino/a for one focus group and Black/African American for another.
Trial design
Ecologic or community
Cross-sectional
Treatments tested in this trial
Focus Group
Other interventionBlack or Hispanic/Latino parents, caregivers or family members of children with ADHD symptoms and/or emotional dysregulation, will discuss: (1) impact of child's mental health, treatments, care received; (2) perceived and actual barriers to future study participation, including discussion about acceptability of bio-specimen collection methods for urine and blood. Each group will comprise individuals who self-identify as Hispanic/Latino, Black, or mixed race. Groups are anticipated to comprise individuals who identify with one or the the other race/ethnicity in order to create space to hear perspectives that may differ between these broadly defined groups.
Treatment groups
Trial outcomes
Primary outcomes
Input and Feedback on Proposed Feasibility Study
Purpose is understanding 1. Parents' priorities regarding their child's mental health 2. Facilitators or barriers to research participation generally 3. Parent input on planned study specifically 4. Specific recommendations for modifying the future feasibility study design 5. Previous CIH intervention use
Sponsors and contacts
Click on the lead sponsor to view all of their trials.